Ji Yao Holding Group Co., Ltd. (300108.SZ)
CNY 0.21
(-12.5%)
CNY 0.21
(-12.5%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.72 Billion CNY | 5.11% |
| 2022 | 2.58 Billion CNY | -9.66% |
| 2021 | 2.86 Billion CNY | 5.63% |
| 2020 | 2.71 Billion CNY | -4.06% |
| 2019 | 2.82 Billion CNY | 8.56% |
| 2018 | 2.6 Billion CNY | 115.97% |
| 2017 | 1.2 Billion CNY | 61.01% |
| 2016 | 748.95 Million CNY | 13.16% |
| 2015 | 661.84 Million CNY | 2.16% |
| 2014 | 647.87 Million CNY | 855.1% |
| 2013 | 67.83 Million CNY | 298.48% |
| 2012 | 17.02 Million CNY | -17.55% |
| 2011 | 20.64 Million CNY | 377.79% |
| 2010 | 4.32 Million CNY | -81.47% |
| 2009 | 23.31 Million CNY | 29.61% |
| 2008 | 17.98 Million CNY | 78.97% |
| 2007 | 10.05 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 2.88 Billion CNY | 3.14% |
| 2024 Q2 | 2.79 Billion CNY | 1.3% |
| 2024 Q1 | 2.75 Billion CNY | 1.43% |
| 2023 Q1 | 2.51 Billion CNY | -2.67% |
| 2023 Q3 | 2.61 Billion CNY | 2.11% |
| 2023 Q4 | 2.72 Billion CNY | 4.22% |
| 2023 Q2 | 2.55 Billion CNY | 1.48% |
| 2023 FY | 2.72 Billion CNY | 5.11% |
| 2022 Q4 | 2.58 Billion CNY | -16.44% |
| 2022 Q2 | 3.03 Billion CNY | 4.15% |
| 2022 Q1 | 2.9 Billion CNY | 1.54% |
| 2022 FY | 2.58 Billion CNY | -9.66% |
| 2022 Q3 | 3.09 Billion CNY | 2.24% |
| 2021 Q1 | 2.7 Billion CNY | -0.15% |
| 2021 Q4 | 2.86 Billion CNY | 2.03% |
| 2021 FY | 2.86 Billion CNY | 5.63% |
| 2021 Q3 | 2.8 Billion CNY | 2.01% |
| 2021 Q2 | 2.75 Billion CNY | 1.64% |
| 2020 Q3 | 2.69 Billion CNY | -0.61% |
| 2020 Q1 | 2.89 Billion CNY | 2.52% |
| 2020 FY | 2.71 Billion CNY | -4.06% |
| 2020 Q2 | 2.7 Billion CNY | -6.54% |
| 2020 Q4 | 2.71 Billion CNY | 0.76% |
| 2019 Q3 | 2.78 Billion CNY | 0.62% |
| 2019 FY | 2.82 Billion CNY | 8.56% |
| 2019 Q4 | 2.82 Billion CNY | 1.35% |
| 2019 Q2 | 2.77 Billion CNY | -0.47% |
| 2019 Q1 | 2.78 Billion CNY | 6.96% |
| 2018 Q3 | 1.89 Billion CNY | 17.81% |
| 2018 Q4 | 2.6 Billion CNY | 37.19% |
| 2018 FY | 2.6 Billion CNY | 115.97% |
| 2018 Q1 | 1.49 Billion CNY | 24.15% |
| 2018 Q2 | 1.61 Billion CNY | 7.62% |
| 2017 Q2 | 852.47 Million CNY | 0.66% |
| 2017 Q1 | 846.88 Million CNY | 13.07% |
| 2017 FY | 1.2 Billion CNY | 61.01% |
| 2017 Q4 | 1.2 Billion CNY | 38.69% |
| 2017 Q3 | 869.46 Million CNY | 1.99% |
| 2016 Q1 | 654.08 Million CNY | -1.17% |
| 2016 Q4 | 748.95 Million CNY | -5.33% |
| 2016 Q3 | 791.15 Million CNY | 7.52% |
| 2016 Q2 | 735.8 Million CNY | 12.49% |
| 2016 FY | 748.95 Million CNY | 13.16% |
| 2015 Q1 | 652.86 Million CNY | 0.77% |
| 2015 FY | 661.84 Million CNY | 2.16% |
| 2015 Q4 | 661.84 Million CNY | -5.49% |
| 2015 Q3 | 700.31 Million CNY | 4.76% |
| 2015 Q2 | 668.47 Million CNY | 2.39% |
| 2014 FY | 647.87 Million CNY | 855.1% |
| 2014 Q4 | 647.87 Million CNY | -0.54% |
| 2014 Q3 | 651.41 Million CNY | 1193.23% |
| 2014 Q2 | 50.37 Million CNY | -27.03% |
| 2014 Q1 | 69.02 Million CNY | 1.76% |
| 2013 Q4 | 67.83 Million CNY | -1.64% |
| 2013 FY | 67.83 Million CNY | 298.48% |
| 2013 Q1 | 36.03 Million CNY | 111.7% |
| 2013 Q2 | 40.75 Million CNY | 13.1% |
| 2013 Q3 | 68.96 Million CNY | 69.2% |
| 2012 Q2 | 31.58 Million CNY | 34.64% |
| 2012 Q3 | 23.83 Million CNY | -24.52% |
| 2012 Q1 | 23.45 Million CNY | 13.61% |
| 2012 FY | 17.02 Million CNY | -17.55% |
| 2012 Q4 | 17.02 Million CNY | -28.59% |
| 2011 Q2 | 7.21 Million CNY | -75.59% |
| 2011 Q1 | 29.56 Million CNY | 584.26% |
| 2011 Q3 | 40.57 Million CNY | 462.11% |
| 2011 Q4 | 20.64 Million CNY | -49.11% |
| 2011 FY | 20.64 Million CNY | 377.79% |
| 2010 Q2 | 20.89 Million CNY | 0.0% |
| 2010 Q4 | 4.32 Million CNY | -48.31% |
| 2010 Q3 | 8.35 Million CNY | -60.0% |
| 2010 FY | 4.32 Million CNY | -81.47% |
| 2009 Q4 | 23.31 Million CNY | 0.0% |
| 2009 FY | 23.31 Million CNY | 29.61% |
| 2008 FY | 17.98 Million CNY | 78.97% |
| 2007 FY | 10.05 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 11.02 Billion CNY | 75.33% |
| Yixintang Pharmaceutical Group Co., Ltd. | 8.75 Billion CNY | 68.929% |
| ZJAMP Group Co., Ltd. | 12.99 Billion CNY | 79.059% |
| Luyan Pharma Co.,Ltd. | 8.81 Billion CNY | 69.139% |